Related content

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

By Bosly A.  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 277-283

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

By Li J.   Wang L.   Shen Y.   Xia Z.   Chen Y.   Chen Q.   Chen Y.   Zeng X.   You J.   Qian Y.   Shen Z.  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 639-645

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin   Nambo Maria J.   Huerta-Guzman Judith   Silva Luis   Neri Natividad  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite

Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience

By Okamoto Akinao   Yanada Masamitsu   Inaguma Yoko   Tokuda Masutaka   Morishima Satoko   Kanie Tadaharu   Yamamoto Yukiya   Tsuzuki Motohiro   Akatsuka Yoshiki   Mizuta Shuichi   Okamoto Masataka   Emi Nobuhiko  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 74-80

Maney Publishing

Access to resources Recommend Favorite

Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

By Deng Lijuan   Song Yuqin   Zhu Jun   Zheng Wen   Wang Xiaopei   Xie Yan   Lin Ningjing   Tu Meifeng   Ping Lingyan   Ying Zhitao   Liu Weiping   Zhang Chen  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 664-671

Springer Publishing Company

Access to resources Recommend Favorite